The significance of clinically insignificant residual fragments after percutaneous nephrolithotomy: an analysis into the relevance of complete stone clearance

Purpose After treatment for kidney stones, residual fragments with a diameter of ≤ 4 mm are traditionally referred to as ‘clinically insignificant residual fragments’.

We hypothesize that patients with these fragments are at an increased risk for stone-related morbidity, such as complaints, hydronephrosis, and stone regrowth, when compared to stone-free patients.

This study aimed to investigate the relevance of complete stone clearance in surgical treatment of urolithiasis.

Methods We conducted a single-center retrospective cohort study.

Patients who underwent percutaneous nephrolithotomy between 2015 and 2020 were included if a CT-scan was available within 6 months after the procedure, and the follow-up duration was at least 1 year.

The stone-free status at the end of the first stone episode during the study period was categorized as fully stone-free, not stone-free with small residual fragments (≤ 4 mm) and not stone-free with large residual fragments (> 4 mm).

Follow-up data were collected, including stone-related events and re-intervention rates.

Results A total of 103 subjects were included with a median follow-up of 21.4 months.

Stone-related events occurred in 10 (29.4%) of the fully stone-free subjects, 20 (58.8%) of the subjects with small residual fragments and 25 (71.4%) of the subjects with large residual fragments.

The stone-related event-free survival per subgroup resulted in a significantly different survival distribution in a log rank test ( p  = 0.008).

Conclusion A complete stone-free status seems to be of fundamental importance for decreasing stone-related morbidity.

Further developments and research should focus on optimizing the full clearance of stone material during PCNL.